Novel Approaches in Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Novel Approaches in Clinical Trials in Brazil

Novel Approaches in Clinical Trials in Brazil – Full Service CRO

Clinical trials are at the forefront of medical research, playing a crucial role in advancing healthcare and improving patient outcomes. Brazil, with its vast and diverse population, advanced healthcare infrastructure, and thriving research community, has become a leading destination for clinical trials in Latin America. In this blog, we explore some of the novel approaches in clinical trials that are revolutionizing healthcare in Brazil.

Virtual Clinical Trials: Harnessing Technological Innovations

Virtual clinical trials, enabled by technological advancements, are transforming the landscape of clinical research in Brazil. These trials leverage digital platforms and remote monitoring tools to collect data, conduct assessments, and engage with participants.

By reducing the need for in-person visits, virtual trials enhance patient convenience, improve recruitment rates, and increase patient retention. Brazil’s adoption of virtual clinical trials facilitates broader participation, including individuals residing in remote areas, ultimately advancing inclusivity and diversity in research.

Real-world Evidence: Augmenting Traditional Trials

Integrating real-world evidence (RWE) into clinical trials has gained traction in Brazil. RWE involves the collection and analysis of data from routine clinical practice, such as electronic health records, claims databases, and patient registries.

By complementing traditional randomized controlled trials (RCTs) with real-world insights, researchers in Brazil gain a comprehensive understanding of treatment outcomes, patient experiences, and long-term effects. This approach accelerates the translation of research into clinical practice, supporting evidence-based decision-making and enhancing patient care.

Adaptive Trial Designs: Optimizing Efficiency and Flexibility

Traditional clinical trials often follow fixed protocols, which can lead to delays and inefficiencies. Adaptive trial designs offer a more flexible approach, allowing modifications to study design based on interim data analysis. Brazil is increasingly embracing adaptive trial designs to optimize resource utilization, reduce costs, and accelerate timelines.

These designs enable seamless adjustments to treatment arms, sample sizes, or endpoints, enhancing efficiency while upholding scientific rigor. By embracing adaptive approaches, Brazil paves the way for more efficient and effective clinical trials.

Novel Approaches in Clinical Trials in Brazil

Novel Approaches in Clinical Trials in Brazil

Novel Approaches in Clinical Trials in Brazil

Patient Engagement and Empowerment: Putting Patients at the Center

Brazil recognizes the importance of patient engagement and empowerment in clinical trials. Patient-centric initiatives ensure that patients’ voices are heard and their needs are addressed, fostering collaboration and trust.

Patient advisory boards, patient-reported outcomes, and shared decision-making frameworks are being implemented in Brazil to involve patients actively in trial design, recruitment, and implementation. By prioritizing the patient perspective, Brazil promotes inclusivity, transparency, and patient-centered care, ultimately improving patient experiences and trial outcomes.

Collaborative Networks and Partnerships: Accelerating Progress

Collaboration between academia, healthcare institutions, pharmaceutical companies, and government bodies is pivotal in driving clinical trial advancements in Brazil. Collaborative networks and partnerships facilitate knowledge exchange, resource sharing, and capacity building, strengthening the country’s research ecosystem.

By fostering interdisciplinary collaborations, Brazil attracts global investment, enhances domestic research capabilities, and positions itself as a hub for cutting-edge clinical trials. These collaborative efforts accelerate progress, promote innovation, and improve healthcare outcomes for the Brazilian population.

Regulatory Excellence: Ensuring Patient Safety and Streamlining Approvals

Brazil’s regulatory agencies, such as the National Health Surveillance Agency (ANVISA), play a critical role in ensuring patient safety and streamlining clinical trial approvals. These agencies have implemented regulatory frameworks that adhere to international standards while addressing the specific needs of Brazil’s healthcare landscape.

Brazil’s commitment to safety and ethics in clinical trials instills confidence among sponsors, researchers, and participants. By maintaining a robust regulatory framework, Brazil encourages responsible research conduct and protects the rights and well-being of trial participants.


Brazil’s commitment to novel approaches in clinical trials is revolutionizing healthcare in Latin America and beyond. The adoption of virtual clinical trials, the integration of real-world evidence, the implementation of adaptive trial designs, and the emphasis on patient engagement and empowerment are reshaping the clinical research landscape in Brazil.

Novel Approaches in Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Novel Approaches in Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Novel Approaches in Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Novel Approaches in Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Novel Approaches in Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Novel Approaches in Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Novel Approaches in Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Novel Approaches in Clinical Trials in Brazil

The Cohortias Team

Novel Approaches in Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Novel Approaches in Clinical Trials in Brazil

Network & Partnerships